Vjhemonc Podcast
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 72:51:50
- More information
Informações:
Synopsis
The video journal of hematological oncology
Episodes
-
The current status of CAR-T therapy in CLL and challenges in this space
03/03/2023 Duration: 08minIn recent years, novel immunotherapies, including CAR-T cell therapy, have greatly improved treatment options for patients with hematological malignancies. Although CAR-T... The post The current status of CAR-T therapy in CLL and challenges in this space appeared first on VJHemOnc.
-
Managing and treating GvHD and other post-transplant complications
23/02/2023 Duration: 09minGraft-versus-host disease (GvHD) is a common complication associated with allogeneic stem cell transplantation (alloSCT), and can occur in acute and... The post Managing and treating GvHD and other post-transplant complications appeared first on VJHemOnc.
-
The role of MRD in multiple myeloma
14/02/2023 Duration: 08minOver the last two decades, treatment approaches for multiple myeloma have significantly changed, and measurable residual disease (MRD) assessment is... The post The role of MRD in multiple myeloma appeared first on VJHemOnc.
-
Novel immune therapies in MDS and challenges in this space
07/02/2023 Duration: 07minMyelodysplastic syndromes (MDS) represent a group of heterogeneous diseases which remain a challenge to treat, and several novel therapies are... The post Novel immune therapies in MDS and challenges in this space appeared first on VJHemOnc.
-
NHL highlights at ASH 2022: Updates in MCL, the role of transplantation, and novel bispecific antibodies
02/02/2023 Duration: 11minThe 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,... The post NHL highlights at ASH 2022: Updates in MCL, the role of transplantation, and novel bispecific antibodies appeared first on VJHemOnc.
-
MPN highlights at ASH 2022: Novel agents, combinations & the role of immunotherapy
26/01/2023 Duration: 14minThe 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,... The post MPN highlights at ASH 2022: Novel agents, combinations & the role of immunotherapy appeared first on VJHemOnc.
-
T-cell lymphoma highlights at ASH 2022: Unmet needs, clinical trial updates & future outlooks
20/01/2023 Duration: 08minThe 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,... The post T-cell lymphoma highlights at ASH 2022: Unmet needs, clinical trial updates & future outlooks appeared first on VJHemOnc.
-
The importance of CD47 in MDS and other targets of interest
17/01/2023 Duration: 07minCD47 is a cell surface protein which is overexpressed in several cancer cells and appears to play an important role... The post The importance of CD47 in MDS and other targets of interest appeared first on VJHemOnc.
-
CLL highlights at ASH 2022: Clinical trial updates, novel BTK inhibitors & combination therapy
09/01/2023 Duration: 07minThe 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA,... The post CLL highlights at ASH 2022: Clinical trial updates, novel BTK inhibitors & combination therapy appeared first on VJHemOnc.
-
Myeloma highlights at ASH 2022: improving access to CAR-T therapy & future outlooks
03/01/2023 Duration: 14minThe 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans,... The post Myeloma highlights at ASH 2022: improving access to CAR-T therapy & future outlooks appeared first on VJHemOnc.
-
Highlights in MDS at ASH 2022: Treating lower-risk & higher-risk disease, trial updates, & more
21/12/2022 Duration: 14minThe 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans,... The post Highlights in MDS at ASH 2022: Treating lower-risk & higher-risk disease, trial updates, & more appeared first on VJHemOnc.
-
iwNHL Session V: Novel therapies in NHL – the role of ADCs
16/12/2022 Duration: 12minThe 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in... The post iwNHL Session V: Novel therapies in NHL – the role of ADCs appeared first on VJHemOnc.
-
iwAL 2022 Session V: Mechanisms of resistance to targeted therapies in AML
06/12/2022 Duration: 12minThe 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the... The post iwAL 2022 Session V: Mechanisms of resistance to targeted therapies in AML appeared first on VJHemOnc.
-
The importance of genomic testing in CLL and its role in clinical decision-making
02/12/2022 Duration: 10minChronic lymphocytic leukemia (CLL) remains a challenging hematological malignancy to treat, and genomic testing has become increasingly important in this... The post The importance of genomic testing in CLL and its role in clinical decision-making appeared first on VJHemOnc.
-
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells
30/11/2022 Duration: 17minThe 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in... The post iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells appeared first on VJHemOnc.
-
Key updates in CLL: novel treatment strategies, the changing role of chemotherapy, and more
25/11/2022 Duration: 11minThe treatment landscape of chronic lymphocytic leukemia (CLL) has transformed over the years with the increased use of Bruton’s tyrosine... The post Key updates in CLL: novel treatment strategies, the changing role of chemotherapy, and more appeared first on VJHemOnc.
-
iwAL 2022 Session IV: The evolving treatment landscape in ALL and the growing role of immunotherapies
22/11/2022 Duration: 16minThe 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the... The post iwAL 2022 Session IV: The evolving treatment landscape in ALL and the growing role of immunotherapies appeared first on VJHemOnc.
-
iwNHL Session III: Exploring the optimal management of R/R follicular lymphoma in an expanding treatment landscape
18/11/2022 Duration: 11minThe 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in... The post iwNHL Session III: Exploring the optimal management of R/R follicular lymphoma in an expanding treatment landscape appeared first on VJHemOnc.
-
iwAL 2022 Session III: Novel targets, combinations and treatment strategies in AML
16/11/2022 Duration: 12minThe 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the... The post iwAL 2022 Session III: Novel targets, combinations and treatment strategies in AML appeared first on VJHemOnc.
-
Recent updates in CML: treatment strategies, clinical trials, and novel agents
11/11/2022 Duration: 15minThe 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) was held in Houston, TX, from September 28-October 1,... The post Recent updates in CML: treatment strategies, clinical trials, and novel agents appeared first on VJHemOnc.